#Switzerland #Geneva #Eli Lilly #Obesity Care #WHO Foundation

WHO Foundation Collaborates with Eli Lilly to Combat Obesity

The WHO Foundation has recently announced a strategic partnership with Eli Lilly and Company aimed at enhancing global health systems dedicated to obesity prevention and care. As one of the most pressing public health challenges worldwide, obesity affects millions and requires urgent attention from the health community.

According to recent statistics, over 2.5 billion adults and more than 390 million children and adolescents are classified as overweight, with a staggering 1 in 8 people globally living with obesity. Alarmingly, the rate of obesity in adults has doubled since 1990, marking an urgent need for coordinated efforts to address this crisis.

In a commitment to tackle this issue, Lilly is contributing $1.68 million to the WHO Foundation over a period extending to 2029. This funding is part of a broader initiative to strengthen health systems that can provide essential support for obesity management, particularly in resource-limited settings. These health systems are crucial for delivering equitable access to early diagnosis, counseling, and care to those affected by obesity, which is increasingly recognized as a global public health priority.

The Importance of Systemic Change

Anil Soni, the Chief Executive Officer of the WHO Foundation, emphasized the significance of this collaboration by stating, "Addressing obesity at scale requires more than individual programs. It necessitates health systems that are equipped to respond comprehensively throughout a person’s life."

The partnership seeks to help health systems identify existing gaps in care and develop a robust framework that integrates evidence-based policies. This includes creating training standards for healthcare professionals and ensuring systems are capable of providing stigma-free care for all age categories over time.

Patrik Jonsson, Executive Vice President and President of Lilly International, highlighted the critical aspect of this initiative, stating, "People living with obesity deserve to receive the care they need to overcome this disease and prevent associated health complications. By supporting health systems in recognizing and addressing obesity, we aim to mitigate the global proliferation of this health condition."

The Broader Implications

The collaboration also focuses on reducing the financial burden associated with obesity, which is projected to surpass $4 trillion by 2035. Empowering health systems to address obesity effectively could potentially lessen this economic impact, as well as mitigate the related health risks that arise from untreated obesity.

WHO Foundation: A Brief Overview

Founded in 2020, the WHO Foundation is an independent organization based in Geneva, Switzerland. Its primary mission is to support the World Health Organization in promoting health equity and responding to urgent health challenges. By galvanizing philanthropic support and fostering impactful partnerships, the Foundation plays a strategic role in advancing health initiatives that save lives.

The collaboration between the WHO Foundation and Eli Lilly marks a vital step in addressing the global obesity epidemic. By focusing on strengthening health systems, both organizations are working towards creating a future where accessible and effective obesity care is a reality for everyone, regardless of their location or circumstances. This partnership not only aims to improve the lives of many but also signifies a unified response to one of the biggest health challenges of our time.